N
NextCure, Inc. (NXTC)
NMS – Real Time Price. Currency in USD
7.04
+0.31 (4.59%)
Market open: Aug 12, 2026, 11:29 AM EDT
6.76
+0.03 (0.48%)
Previous after-hours: Aug 11, 2026, 7:45 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
7.04
+0.31 (4.59%)
Market open: Aug 12, 2026, 11:29 AM EDT
6.76
+0.03 (0.48%)
Previous after-hours: Aug 11, 2026, 7:45 PM EDT
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company’s product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer’s disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
| Name | Position |
|---|---|
| Dr. Lieping Chen M.D., Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
| Dr. Sebastien Maloveste Ph.D. | Senior Vice President of Business Development |
| Dr. Timothy Mayer Ph.D. | Chief Operating Officer |
| Dr. Udayan Guha M.D., Ph.D. | Chief Medical Officer |
| Mr. Kevin G. Shaw | Senior VP & General Counsel |
| Mr. Michael S. Richman MSBA | Co-Founder, CEO, President & Director |
| Mr. Sourav Kundu Ph.D. | Senior Vice President of Development & Manufacturing |
| Mr. Steven P. Cobourn CPA | Chief Financial Officer |
| Date | Type | Document |
|---|---|---|
| 2026-08-10 | 425 | tm2622749d1_425.htm |
| 2026-08-06 | 8-K | nxtc-20260806x8k.htm |
| 2026-07-16 | 425 | tm2620692d2_425.htm |
| 2026-07-14 | 425 | tm2620428d1_8k.htm |
| 2026-06-25 | 8-K | nxtc-20260618x8k.htm |
| 2026-06-01 | 8-K | nxtc-20260601x8k.htm |
| 2026-05-07 | 8-K | nxtc-20260507x8k.htm |
| 2026-05-07 | 10-Q | nxtc-20260331x10q.htm |
| 2026-04-24 | DEFA14A | tm261451d5_defa14a.htm |
| 2026-04-24 | DEF 14A | tm261451-3_def14a.htm |